Management of Prostatomegaly (Izam-I-Ghudda-I-Mazi) in Unani System of Medicine: An Overview
Prostatomegaly is the enlargement of prostate gland in elderly males which results urinary symptoms in them. The prevalence of prostatomegaly is age dependent with the initial development usually after 40 years reaching approximately 90 percent after 70 years of age. Since prostatomegaly itself is not a fatal disease but its most important outcome is urinary flow obstruction, which is miserable for the patient and affects physical activities and mental health of the person. The symptoms of prostatomegaly include hesitancy, increased frequency of micturition, dribbling, narrow stream, nocturia, retention of urine, urgency, incontinence etc. Great Unani physician have been managing depending upon the age and nature of the symptoms. The great ancient scholars have also managed this ailment by different regimental therapies, pharmacotherapy and dietotherapy.
Islam4 and Qamar Alam Khan5
drhaiderjamiahamdard@gmail.com regimental therapies, pharmacotherapy and dietotherapy.
Keywords: Prostatomegaly; Warm-e-Ghudda-e-Mazi; Micturition; Unani Medicine Management of Prostatomegaly (Izam-I-Ghudda-I-Mazi) in Unani System of Medicine: An Overview
Introduction
In classical literature of Unani System of Medicine prostatomegaly has been mention as Izam-i-Ghudda-i- Mazi Sada, Sala`a Ghudda-e-Mazi, Warm-e-Ghudda-e-Mazi, and Warm-e-Unq-e-Masanah [1, 2, 3]. It is a condition J Urol Nephrol
resembling the clinical feature discussed under *Usr-i-Bawl* (Dysuria), *Ihtibas-i-Bawl* (Retention of Urine) and *Taqtir-i-Bawl* (Dribbling of Urine), narrow stream, urgency, incontinence etc. in classical literature of USM. Unani Physicians have mentioned that *Warm-i-Aza-i-Mujawira* (Inflammation/swelling of neighboring organs) of urethra may compress it causing obstruction to flow urine [4, 5]. These conditions may be correlated to Benign Prostatic Hyperplasia (BPH) where enlarged prostate compresses prostatic urethra and produces symptoms such as hesitancy, intermittent voiding, diminished stream, incomplete emptying, and post void leakage.
It is caused by the abnormal accumulation of *Balgham Ghaliz* or *Mawad-e-Ghaliz* (Thick phlegm) which has been mentioned as the leading cause of swelling (*Auram*) / inflammation of any *Azw Ghudadi* (Gland) of the body [6]. It is characterized by urinary frequency, hesitancy, strangury and urgency with weak urinary stream. Patient may have feeling of incomplete bladder emptying, straining and terminal dribbling. Acute and chronic urinary retention may also be present. *Unani* physicians are treating the symptoms of BPH for centuries with safe *Unani* herbal remedies.
**Review of Literature**
Cause of Prostatomegaly is not much exactly understood but it is now clear that androgens have central role in its development [7]. In Unani system of medicine Prostatomegaly has been described under the headings of *Sala’a* *Ghudda-e-Mazi*, *Warm-e-Ghudda-e-Mazi*, and *Warm-e-Unq-e-Masanah*. However mostly in our classical texts symptomatic treatment of Prostatomegaly can be found under different headings like *Ehtabass-e-Baul*, *Taqteurul Baul*, *Usr-e-Baul* etc [8]. Father of medicine Hippocrates (*Buqrat*) described *Auram* (swellings) because of abnormality in four humors (*Akhlate arba*), a soft swelling is due to (Khilt-e-Balgham), a hard swelling (*Warm-e-Salb*) or *Sala’a* due to black humour *Khilt-e-Sauda* and third type is combination of the two (*Balgham and Sauda*). Attiba have categorized *Sala’a* (tumor) under the heading of *Warm* (an abnormal growth or swelling) [9]. Maseehi described *Sala’a* as a swelling or over growth due to Balgham or *Mawad-e-Galeez* [10].
The paradigm for the management of Prostatomegaly has shifted from being purely surgical to a combination of medical and surgical management in past two decades. Though trans-urethral resection of prostate (TURP) remains the gold standard in Prostatomegaly management, new clinical research has opened up avenues of medical management. Medical management is effective in reducing the symptoms and prostate size, but allopathic medicine do have various side effects like erectile dysfunction, loss of libido, impotency, vertigo, cardiovascular disorders etc [11, 12]. *Unani* physicians are treating the symptoms of Prostatomegaly by different Unani formulation and regimen.
**Incidence**
Benign prostatic hyperplasia (BPH) prevalence in Ghana is responsible for 60% acute retention of urine and 28.6% of haematuria. Worldwide prevalence of BPH varies from 20-62% in men over 50 years and this includes USA, UK, Japan and Ghana. BPH co-existing with PC – Reports from USA, UK and Japan and Ghana reveal moderate association of BPH and PC is 3-20%.
Prostate Cancer prevalence – There is high prevalence in USA, Scandinavian Countries, African Americans (AA) and Caribbean blacks. Ghana, Trinidad & Tobago have reported high prevalence of 6–10% in men aged 50 years and above. Overall PC causes 18% of disorders of the prostate gland. The worldwide incidence in men over 50 years is 11.7% that is 15th commonest of new cancers worldwide, 19% of new cancers in developed countries and 5% in developing countries [13]. The prevalence per population is lowest in Asia/China 1.9% or 10/100,000 in Caucasian Americans 1.4-2.4% or 104/100,000, African Americans 2.2-5.1% or 272/100,000, in Caribbean Men about 5-10% and we have established in Ghanaian Men from 6.3%-7% which is on the high side [14, 15].
Management of Prostatomegaly by different Unani formulation and regimental therapies.
- *Ilaj-Bil-Ghiza* (Dietotherapy)
- *Ilaj-Bil-Dawa* (Pharmacotherapy)
- *Ilaj-Bil-Tadbeer* (Regimenal therapy)
- *Ilaj-Bil-Yad* (Surgery)
- *Usul-i-Ilaj* (Principles of Treatment)
- *Tanqiya* (Evacuation of Morbid matter i.e. *Mawad-e-Ghaliz*).
- *Talyin-o-Irkha-o-Tahlil-i-Waram* (To soften, relax and resolve the swelling / *Auram*).
- *Ikhraj-i-Bawl* *Bazari-a-Qasatir* (Urethral catheterization) in acute retention.
- *Ilaj-Bil-Dawa* (Pharmacotherapy)
- Oral Administration of *Maul-Usul* with castor oil.
- Oral Administration of *Joshanda* (decoction) of following drugs (Table 1) along with Gulqand in the morning [16].
| Drugs | Miqdaar (Quantity) | ||||
|---|---|---|---|---|---|
| Unani Names | Botanical Names | ||||
| Badranjboya | Nepeta ruderalis Ham. | 10.5gm | |||
| Badiyan | Foeniculum vulgare Gaertn. | 10.5gm |
Table 1: Ingredients of _Joshanda_. • Oral administration of _Joshanda_ (decoction) of Badiyan (Foeniculum vulgare Gaertn.) 10.5
• Oral administration of Safoof (Powder) of following
| Drugs | Miqdaar (Quantity) | ||||
|---|---|---|---|---|---|
| Unani Names | Botanical Names | ||||
| Zanjabil | Zingiber officinale Roscoe. | 4.5-7.5gm | |||
| Turbud | Ipomea turpethum Br. | 4.5-7.5gm | |||
| Mastagi | Pistacia lentiscus Linn. | 4.5-7.5gm |
Table 2: Ingredients of _Safoof_. • Oral administration of 3.5gm of _Habb-e-Khizran_ (Pills Khizran) (prepared with fallowing ing
| Drugs | Miqdaar (Quantity) | ||||
|---|---|---|---|---|---|
| Unani Names | Scientific Names | ||||
| Ayarij-i-Fayqra | Ayarij-i-Fayqra | 10.5gm | |||
| Ghariqun | Agaricus alba Linn. | 8.75gm | |||
| Shahm-i-Hanzal | Cirullus colocynthis Schard. | 5.25gm | |||
| Turbud | Ipomea turpethum Br. | 24.5gm | |||
| Jaoshir | Ferula galbaniflua Boiss. | 4.5gm | |||
| Nawsharad | Sal ammoniac | 7gm | |||
| Saqmuniya | Convolvulus scammonia Linn. | 4.5gm | |||
| Juice of Gandana | Allium ampeloprasum Linn | Mix with all above |
Table 3: Ingredients of _Habb-e-Khizran._ • Oral administration of 7-10.5gm _Habb-e-Wasili_ (Pills Wasili) prepared with fallowin
| Drugs | Miqdaar (Quantity) | ||||
|---|---|---|---|---|---|
| Unani Names | Scientific Names | ||||
| Sumbul al Tib | Nardostachys jatamansi | 03.5gm | |||
| Salikha | Cinnamomum aromaticum Nees | 03.50gm | |||
| Shahm-i-Hanzal | Cirullus colocynthis Schard. | 17.50gm | |||
| Turbud | Ipomea turpethum Br. | 24.5gm | |||
| Habb-i-Balsan | Fruit of Commiphora opobalsamum Linn. | 03.50gm | |||
| Asarun | Asarun europaeum | 03.50gm | |||
| Saqmuniya | Convolvulus scammonia Linn. | 14.00gm | |||
| Ud-i-Balsan | Commiphora opobalsamum Linn. | 03.50gm | |||
| Mastagi | Pistacia lentiscus Linn. | 03.50gm | |||
| Darchini | Cinnamomum zeylanicum Linn. | 03.50gm | |||
| Zafaran | Crocus sativus Linn. | 03.50gm | |||
| Sibr | Aloe vera Linn. | 56.00gm |
Table 4: Ingredients of _Habb-e-Wasili_. • Oral administration of _Safoof_ (Powder) of _Ustukhudus_ (_Lavandula stoechas_ Linn) i
| Ustukhudus | Lavandula stoechas Linn | 17.50gm |
|---|---|---|
| Namak Hindi | Common salt | 07.00gm |
Table 5: Ingredients of _Habb-e-Wasili_. • Oral administration of _Safoof_ (Powder) of _Ustukhudus_ (_Lavandula stoechas_ Linn) i
Table 4: Ingredients of Habb-e-Wasili.
- Oral administration of Safoof (Powder) of Ustukhudus (Lavandula stoechas Linn) in a dose of 1gm with 12gm Of Itrifal Saghir, followed by administration of Joshanda (decoction) of Gul-i-Khatmi (Flower of Althae officinalis Linn.) 3gm., Mawiz Munaqqa (Vitis vinefera Linn.) 10 pices, Tukhm-e-Kasni (seed of Cichorium intybus Linn.) 6gm. Mixed with 12ml of honey and sprinkled with 6gm of Asphol (Plantago ovata Forsk).
- Abzan (Sitz bath) with Joshanda (decoction) of following drugs [18] (Table 5).
| Drugs | Miqdaar (Quantity) | |||||
|---|---|---|---|---|---|---|
| Unani Names | Botanical Names | |||||
| Babuna | Matricaria chamomilla Linn. | 4.5-7.5gm | ||||
| Shibit | Anethum sowa Roxb. | 4.5-7.5gm | ||||
| Bekh-e-Khatmi (Root) | Pistacia lentiscus Linn. | 4.5-7.5gm |
Table 6: Ingredients of _Joshanda_ with _Abzan_. • _Abzan_ (Sitz bath) with _Joshanda_ (decoction) of following drugs (Table 6).
| Drugs | Miqdaar (Quantity) | |||||
|---|---|---|---|---|---|---|
| Unani Names | Botanical Names | |||||
| Babuna | Matricaria chamomilla Linn. | 4.5-7.5gm | ||||
| Nakhuna (Pods) | Trigonella uncata Boiss. | 4.5-7.5gm | ||||
| Banafsha | Viola odorata Linn. | 4.5-7.5gm | ||||
| Shih | Artemisia maritima Linn. | 4.5-7.5gm | ||||
| Qaysum | Achillea millefolium Linn. | 4.5-7.5gm | ||||
| Marzanjosh | Oliganum vulgare Linn. | 4.5-7.5gm |
Table 7: Ingredients of _Joshanda_ with _Abzan_. • _Abzan_ (Sitz bath) with _Joshanda_ (decoction) of following drugs (Table 7) i
| Drugs | |||||
|---|---|---|---|---|---|
| Unani Names | Botanical Names | ||||
| Babuna | Matricaria chamomilla Linn. | ||||
| Nakhuna ( Pods) | Trigonella uncata Boiss. | ||||
| Banafsha | Viola odorata Linn. | ||||
| Shibit | Anethum sowa Roxb. | ||||
| Barg-i-Turb | Raphanus sativus Linn. | ||||
| Bazr-i-Katan | Linum usitatissimum Linn. | ||||
| Khar Khasak | Tribulus terristris Linn. | ||||
| Karafs | Apium graveolens Linn. | ||||
| Parsiyaoshan | Adiantum capillus-veneris Linn. | ||||
| Khatmi | Althaea officinalis Linn. | ||||
| Hulba | Trigonella foenum-graeceum Linn. | ||||
| Sabus (Wheat husk) | Wheat husk | ||||
| Barg-i-Karnab (Cabbage) | Cabbage | ||||
| Drugs | Miqdaar (Quantity) | ||||
| Unani Names | Botanical Names | ||||
| Babuna | Matricaria chamomilla Linn. | 4.5-7.5gm | |||
| Shibit | Anethum sowa Roxb. | 4.5-7.5gm | |||
| Bekh-i-Khatmi (Root) | Pistacia lentiscus Linn. | 4.5-7.5gm |
Table 8: Ingredients of _Joshanda_ with _Abzan_.
• Natul (Irrigation) with Joshanda (decoction) of following drugs (Table 8).
| Drugs | Miqdaar (Quantity) | |||||
|---|---|---|---|---|---|---|
| Unani Names | Botanical Names | |||||
| Babuna | Matricaria chamomilla Linn. | 4.5-7.5gm | ||||
| Ard-i-Hulba (Flour of seed) | Trigonella foenum-graeceum Linn. | 4.5-7.5gm | ||||
| Khubazi | Malva sylvestris Linn. | 4.5-7.5gm | ||||
| Banafsha | Viola odorata Linn. | 4.5-7.5gm | ||||
| Nakhuna (Pods) | Trigonella uncata Boiss. | 4.5-7.5gm |
Table 9: Ingredients of paste. • Application of paste of _Shora Qalmi_ (Potassium nitrate) on the bladder area. • Application of
Table 9: Ingredients of paste.
- Application of paste of Shora Qalmi (Potassium nitrate) on the bladder area.
- Application of Roghan-i-Khasak at pubic region.
- Application of Roghan-i-Babuna at pubic region.
- Application of Roghan-i-Gul at pubic region.
- Application of hot paste of Rewand Chini (Rheum emodi Wall.) mixed with Arq-i-Badyan at pubic area, testicles and around urethra.
Compound Unani Drugs
The compound formulations which have been given in Unani classical literature for the management of prostatomegaly are discussed below as in Table 10.
| S.No. | Compound Unani Drugs | Doses | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 | Itrifal Ghudadi [17] | 5gm twice a day. | ||||||
| 2 | Habb-i-Ayarij [5] | 2 pills twice a day. | ||||||
| 3 | Itrifal Saghir [17] | 5-10gm at bed time. | ||||||
| 4 | Sharbat Dinar [16] | 10-20ml after every meal. | ||||||
| 5 | Banadiq-ul-Bazur [5] | 2 pills thrice a day. | ||||||
| 6 | Arq-i-Mako [16] | 125ml twice a day. | ||||||
| 7 | Roghan-i-Khasak [18] | Local application on pubic region. | ||||||
| 8 | Habb-i-Hindi [16] | 2 pills thrice a day. | ||||||
| 9 | Roghan-i-Babuna [18] | Local application on pubic region. | ||||||
| 10 | Roghan-i-Gul [18] | Local application on pubic region. |
Table 10: Compound Formulation (Murakkab Adviya). _Ilaj-Bil-Tadbeer_ (Regimenal therapy) • Natul (Irrigation) • Urethral catheteri
- Aghziya Muwallid-i-Sawda
- Aghziya Muwa;;id-i-Balgham Investigation Required
- USG (W/A).
- Serum prostate-specific antigen (PSA).
- Uroflowmetry.
Methodology
The databanks used to get information from journals and articles are Google, PubMed, Science Direct, Scopus and Google Scholar. For the search of primordial and current Unani classical literature author visited Library of Regional Research Institute of Unani Medicine (RRIUM), Srinagar, J & K, India and School of Unani Medical Education and Research Jamia Hamdard, New Delhi.
Conclusion
The morphological anatomy of the prostate gland has been established. They are the peripheral zone (PZ), transitional zone (TZ), central zone (CZ), the anterior fibro muscular area and the pre prostatic area. The contributions of zonal areas in a normal gland are PZ 70- 80%, TZ 10%, CZ 20%. In benign prostatic hyperplasia/hypertrophy/enlargement (BPH/BPE), only the transitional zone is affected and constitutes 100% of prostatomegaly. So it has been observed that these formulations when used clinically have marked effect in reducing the volume of the prostate by acting on the transitional zone. To overcome the misery of the prostatic symptoms and to maintain the proper sleep, the different regimenal therapies employed by Unani physician from time to time has in general gained the importance of Unani system of medicine for prostatomegaly.
References
-
Jeelani HG (1923) Makhzanul Jawahir (Tibbi Lugat), Manager Tibbi Kutbkhana, Lahore, 607: 917-918.
-
Alqamri AMH (2010) Ghina Muna 1st (Edn), CCRUM, New Delhi, 497: 309-310.
-
Ibne Sena (2010) Alqanoonfittib (Urdu translation by Ghulam Hasnain kantoori), Ejaz publishing House, New Delhi, 3: 1023.
-
Ibn Sina (1411) Al-Qanun-fil-Tibb, (Part II), Jamia Hamdard, New Delhi, 3: 762-781.
-
Mohammad Azam Khan (1906) Iksir-i-Azam, Matab Nami, Munshi Naval Kishor Lucknow, 3: 498-516.
-
Nafis B, Iwaz (1326) Sharah-al-Asbab-wa-al-Alamat, Matab Nami, Munshi Naval Kishor Lucknow, 2: 193- 205.
-
Tho TD, Thanh NV, Thuc DV, Khanh Hy DT, Bien TK, et al. (2005) Assessment of therapeutic effect of softgel Crinum latifolium for benign prostate hypertrophy. Ministry of Health, Hanoi.
-
Qarabadeen Azam wa Akmal (2005) Urdu translation, CCRUM, New Delhi, 250-253.
-
Ali Ibn Abbas Majoosi (2010) Kamil-e-Sana`ah (Urdu translation by Ghulam Hasnain Kantoori), Idara kitabulshifa, New Delhi, II: Maqalah 9th, 2: 528-529.
-
Ibn Qafful Masihi (2000) Kitab ul Umdah fil Jarahat, CCRUM, New Delhi, I: 162.
-
Manoranjan Sahu, Ramesh Bhat, Kala Suhas Kulkarni (2003) Clinical evaluation of Himplasia in benign prostate hyperplasia. Medicine update 1(11): 75-78.
-
Mark HE, Mark G (2007) Benign Prostate Hyperplasia management in primary care screening and therapy. HSR&D evidence synthesis pilot program-BPH. US Department of veteran affairs Health services research and Development services.
-
Surveillance Epidemiology Age Adjusted Cancer incidence in men in United States 1975-2005 “Surveillance Epidemiology and End Results” Program (SEER) Division of cancer control and population sciences. National Cancer Institute USA.
-
Osegbe DN (1997) Prostate cancer in Nigerians: facts and nonfacts. J Urol 157(4): 1340-1343.
-
Haas GP, Delongchamps N, Brawley OW, Wang CY, Dela RG (2008) World Wide Epidemiology of Prostate cancer: perspective from autopsy studies. Can J Urology 15(1): 3866-3871.
-
Mohammad Azam Khan (2006) Rumuz-i- Azam, CCRUM, New Delhi, II: 155-159.
-
Mohammad Azam Khan (1906) Iksir-i-Azam, Matab Nami, Munshi Naval Kishor Lucknow, IV: 289-308.
-
Muhammad Bin Zakariya Razi (1308) Kitab-al-Hawi- fil-Tibb, Daira Al-Maarif-Al-Usmaniya, Hyderabad, X: 153-188.
- Results of 6-Month Follow-Up of Patients After B-Turp and Thulep
- The Effect of Drinking Water with a High Content of Antimony and Arsenic on the Dynamics of their Distribution in the Kidneys and the Renal Excretory Function in Rats
- Effectiveness and Safety of Tansurethral Thulium Laser Enucleation of the Prostate in the Treatment of BPH: Review
- A Systematic Review on Molecular Pathophysiology Involved in Chronic Kidney Disease and the Role of Animal Models in Drug Discovery to Manage in Chronic Kidney Disease - An Update
- Functional Development of Kidneys in Human Ontogenesis
- Testicular Metastasis: Uncommon Prostate Cancer Case Report